Market Mover: Schrodinger (SDGR) Up at Midday June 23

Equities Staff  |

Schrodinger Inc (NASDAQ: SDGR) shares climbed 5.33%, or $1.46 per share, as on 12:10:35 est today. Since opening the day at $27.56, 239,600 shares of Schrodinger have traded hands and the stock has moved between $28.89 and $27.56.  

Already the company has a YTD change of 21.42%.

Schrodinger anticipates its next earnings on 2022-08-11.

For technical charts, analysis, and more on Schrodinger visit the company profile.

About Schrodinger Inc

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

To get more information on Schrodinger Inc and to follow the company's latest updates, you can visit the company's profile page here: Schrodinger Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content